Therapy-related myeloid neoplasms after 177Lu-DOTATATE therapy for metastatic neuroendocrine neoplasia: CPX-351 consolidated by allogeneic stem cells transplantation as applicable therapeutic strategy

Leuk Lymphoma. 2023 Jul-Aug;64(7):1355-1357. doi: 10.1080/10428194.2023.2199896. Epub 2023 Apr 12.

Guillaume Berton¹, Robin Arcani^{2

3}, Antoine Tichadou^{1

4

5}, Laure Farnault¹, Pauline Roche¹, Julien Colle^{1

4

5}, Vadim Ivanov¹, Cédric Mercier¹, Anne-Laure Couderc⁶, Regis Costello^{1

4

5}, David Taïeb⁷, Geoffroy Venton^{1

4

5}

¹ Hematology and Cellular Therapy Department, La Conception, University Hospital of Marseille, France.
² Internal Medicine and Therapeutics department, CHU La Timone, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
³ Center for Cardiovascular and Nutrition research (C2VN), Aix-Marseille University, Marseille, France.
⁴ TAGC, INSERM, UMR1090, Aix-Marseille University, Marseille, France.
⁵ SMARTc Unit, Pharmacokinetics Laboratory, Aix-Marseille University, Marseille, France.
⁶ Geriatric and Therapeutic Unit, Internal Medicine, CHU Sainte Marguerite, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
⁷ Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, France.

No abstract available

Keywords: Haploidentical allogeneic stem cells transplantation; Secondary acute myeloid leukemia; cytarabine; daunorubicin; overall survival.

MeSH terms